share_log

Novavax | 4: Statement of changes in beneficial ownership of securities-Officer Trizzino John

Novavax | 4: Statement of changes in beneficial ownership of securities-Officer Trizzino John

諾瓦瓦克斯醫藥 | 4：持股變動聲明-高管 Trizzino John
美股SEC公告 ·  08/22 04:50

牛牛AI助理已提取核心訊息

On August 19, 2024, John Trizzino, EVP, CCO, and CBO of Novavax Inc (NVAX), completed a stock transaction involving the company's common stock. Trizzino exercised options to acquire 655 shares at no cost, and subsequently sold 317 shares at a price of $13.9 per share. Following these transactions, Trizzino's direct holdings in Novavax amounted to 28,310 shares. The total market value of the disposed shares was $4,406.3.
On August 19, 2024, John Trizzino, EVP, CCO, and CBO of Novavax Inc (NVAX), completed a stock transaction involving the company's common stock. Trizzino exercised options to acquire 655 shares at no cost, and subsequently sold 317 shares at a price of $13.9 per share. Following these transactions, Trizzino's direct holdings in Novavax amounted to 28,310 shares. The total market value of the disposed shares was $4,406.3.
2024年8月19日，諾瓦瓦克斯醫藥（NVAX）公司的EVP，CCO和CBO約翰·特里齊諾完成了一項關於該公司普通股的股票交易。特里齊諾行使了期權，無償取得了655股股份，並以每股13.9美元的價格出售了317股股份。在此次交易後，特里齊諾在諾瓦瓦克斯的直接持股總數達到了28,310股。出售股份的總市值爲4,406.3美元。
2024年8月19日，諾瓦瓦克斯醫藥（NVAX）公司的EVP，CCO和CBO約翰·特里齊諾完成了一項關於該公司普通股的股票交易。特里齊諾行使了期權，無償取得了655股股份，並以每股13.9美元的價格出售了317股股份。在此次交易後，特里齊諾在諾瓦瓦克斯的直接持股總數達到了28,310股。出售股份的總市值爲4,406.3美元。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    熱議
    美股
    股票代碼最新價升跌幅

    暫無數據

    資訊熱榜
    更新時間